Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 01. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8934  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178664  
   
Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity.
J Robot Surg
Zorzi F, Amodeo A, Moretto S, Ingels A, Crestani A, Di Gianfrancesco L, Giannarini G, Tulone G, Simonato FA, Liguori G, Panthier F, Pandolfo SD, Contieri R, Perdonà S, Simonato A, Porreca A, Pavan N, Claps F.
PMID: 42223755 [PubMed - indexed for MEDLINE]


Renal and Extramedullary Involvement Revealing Atypical Multiple Myeloma: A Case Report and a Literature Review.
Tunis Med
El Ati Z, Hadhri A, Dahmane R, Ayed A, Hadj Brahim M, Boukadida R, Zouaghi K, Jaballah L, Raies L.
PMID: 42223467 [PubMed - indexed for MEDLINE]


Artificial intelligence-assisted urine cytology based on the Paris System for Reporting Urothelial Carcinoma.
Cancer Cytopathol
Chen L, Cao X, Lu Z, Liu L, Sun M, Wu Y, Zhang W.
PMID: 42223163 [PubMed - indexed for MEDLINE]


Perioperative Apalutamide in High-Risk Localized Prostate Cancer.
N Engl J Med
Taplin ME, Gleave M, Shore ND, Lopez-Gitlitz A, Kretschmer A, Efstathiou E, Nguyen PL, Damião R, Kamoto T, Ross A, Briganti A, Hadaschik BA, Heidenreich A, Juárez Soto Á, Ye H, Gotto G, Rooney B, Tian SK, Wetherhold L, Miladinovic B, McCarthy SA, Evans CP, Kibel AS, PROTEUS Investigators.
PMID: 42223077 [PubMed - as supplied by publisher]


PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer.
N Engl J Med
Agarwal N, Matsubara N, Azad AA, Saad F, Mateo J, Jiang S, Ye D, Voog E, Shore ND, Çil T, Vulsteke C, Chung HJ, Zschäbitz S, Laird AD, Zhang X, Nandoskar P, Chetcuti SF, Wang F, Fizazi K.
PMID: 42223064 [PubMed - as supplied by publisher]


Uncontrolled Hypertension Leading to the Diagnosis of Renal Cell Carcinoma: A Case Report.
Cureus
Loja J, Nascimento RF, Caldeira E, Moniz ME, Freitas JM.
PMID: 42222619 [PubMed]


Characteristics, treatment patterns, and outcomes of patients with metastatic prostate cancer during 2014-2022 in Pirkanmaa, Finland-an observational study.
Ther Adv Urol
Moisander M, Hölsä O, Teittinen K, Kysenius K, Kosunen M, Lehmus L, Murtola TJ.
PMID: 42221687 [PubMed]


[Expression of NF-κB, EGFR, and HER3 in castration-resistant prostate adenocarcinoma: a clinical and molecular study of 88 Moroccan patients].
Pan Afr Med J
Sadaoui I, Sadaoui I, Joutei HAH, Benomar H, Nadifi S.
PMID: 42221598 [PubMed - indexed for MEDLINE]


Radiological Presentations of Prostatic Carcinoma Patients: A Retrospective Observational Study From a Tertiary Care Oncology Setup.
Cureus
Altaf MO, Nasir K, Mughal Z, Niaz MM.
PMID: 42220745 [PubMed]


Efficacy and safety of immune checkpoint inhibitors combined with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: a risk-stratified systematic review and meta-analysis.
Front Immunol
Rao Y, Zhang J, Gu X, Han J, Ye Z.
PMID: 42220544 [PubMed - indexed for MEDLINE]


Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes.
Front Immunol
Chen ST, Zhou DR, Ge YJ, Chang L, Guo SH, Wu GS, Feng NH.
PMID: 42220493 [PubMed - indexed for MEDLINE]


Identification of succinylation-related genes in bladder cancer: integration of single-cell and transcriptomic data.
Front Immunol
Yang J, You Z, Mo H, Pu J, Shen G, Miao Z.
PMID: 42220482 [PubMed - indexed for MEDLINE]


Radiomics-Based Machine Learning versus the MAP Score for Predicting Haematocrit Decline after Laparoscopic Partial Nephrectomy.
J Coll Physicians Surg Pak
Dogan Y, Ozdes AA, Yildirim M, Beler M, Kartal D, Pirincci N.
PMID: 42219835 [PubMed - indexed for MEDLINE]


Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical Trial.
J Appl Clin Med Phys
Schaly B, Mendez LC, Khawaja M, Black A, Warner A, Hoover DA.
PMID: 42219614 [PubMed - indexed for MEDLINE]


Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study.
Cancer Res Commun
Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W.
PMID: 42219553 [PubMed - as supplied by publisher]


Histotripsy-induced acute kidney injury following liver tumor treatment: A preliminary report of 9 cases.
J Vasc Interv Radiol
Poe LL, Kisting AL, Mendiratta-Lala M, Abi-Jaoudeh N, Breuer JA, Fidelman N, Raman SS, Lee FT Jr, Lokken RP, Caoili EM, Shah R, Hinshaw JL.
PMID: 42218940 [PubMed - as supplied by publisher]


Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK biobank.
Brief Bioinform
Lu J, Thygesen JH, Beaumont RN, Weedon MN, Green HD.
PMID: 42218711 [PubMed - in process]


Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.
Jpn J Clin Oncol
Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
PMID: 42218684 [PubMed - as supplied by publisher]


Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.
J Clin Oncol
Necchi A, de Jong JJ, Maiorano BA, Proudfoot JA, Basile G, Cigliola A, Mercinelli C, Tateo V, Piacentini M, Crupi E, Pastorino GL, Latini G, Tomasi E, Davicioni E, Moschini M, Brembilla G, Colecchia M, de Cobelli F, Ross JS, Madison R, Tambaoan CFB, Briganti A, Montorsi F.
PMID: 42218654 [PubMed - as supplied by publisher]


Cytoreductive radical prostatectomy in patients with high-volume metastatic prostate cancer achieving deep biochemical response to contemporary systemic therapy: a multicentre, prospective cohort study.
BMC Med
Huang C, Guo H, Gao W, Huang M, Ji G, Rui R, He S, Yu Y, Zhang N, Tian Y, Niu Y, Li X, Zhou L.
PMID: 42218463 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 178664    Seite 1 von 8934  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1